Innovision Capital

Founded in 2016, InnoVision Capital is widely recognized as a leading next-generation Private Equity manager that has been focusing on investing in ESG space, primarily green energy / clean tech, food security and healthcare sectors for more than 20 years with strong and proven track records. InnoVision endeavors to implement the best ESG practices among all the financial institutions with proven track record in pan-Asia region. The sustainable strong alpha creation comes from 3 main drivers, including investing in industry leading companies with enormous long-term growth potential and attractive entry valuation, disciplined exit strategy through multiple channels and value creation to portfolios and investors. InnoVision has obtained UNPRI signatory and is voluntarily complied with Article 6 and supports United Nations Sustainable Development Goals, “UN SDGs”, investing in companies that align with the SDGs. The Founder & CEO of InnoVision, Lane Zhao, a 20-year veteran in the private equity industry, has been focusing on ESG investment since his time prior to InnoVision at KKR as one of the founding stage members of the Asia business from 2006 to 2016. Lane pioneered the first ESG investment of KKR Asia, i.e. United Envirotech, a leading Membrane-based Integrated Environmental Solutions Provider headquartered in Singapore. InnoVision currently has both USD and RMB funds under management, with deep industry knowledge, top-notch deal sourcing network, strong value creation capabilities, best-in-class internal processes, successful experiences in global capital markets, and deep insights into regulation trends. InnoVision has had many successful investments since its inception, such as Beike, JD Logistics, China Securities, WuXi AppTec, Wanhua, Kuaishou, Inovance, Lvkon, Eswin, 58 Group, Channel Soft, Vtown, Neurophth, CATUG Biotechnology, iCamuno Biotherapeutics, Kedu Healthcare, Butel, Swan Daojia, Lalami, etc.